Suchergebnisse - "Neidhart, Jeffrey D."

PubPharm (8)

1

Tocilizumab in nonventilated patients hospitalized with Covid-19 pneumonia

enthalten in: bioRxiv.org | 2022

von Salama, C. | Han, J. | Yau, L. | +17

2

Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen

enthalten in: Experimental hematology | 2022

von Afari, J. | Spektor, T. | Turner, C. | +13

3

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

enthalten in: The New England journal of medicine | 2021

von Salama, C. | Han, J. | Yau, L. | +17

CommentIn: N Engl J Med. 2021 Apr 15;384(15):1473. - PMID 33657286

4

A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer

enthalten in: OncoTargets and therapy | 2016

von Garon, E. | Neidhart, J. | Gabrail, N. | +3

5

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

enthalten in: Investigational new drugs | 2013

von Weiss, G. | Chao, J. | Neidhart, J. | +22

6

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

enthalten in: Investigational new drugs | 2013

von Weiss, G. | Chao, J. | Neidhart, J. | +22

7

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

enthalten in: Investigational new drugs | 2013

von Weiss, G. | Chao, J. | Neidhart, J. | +22

8

First-in-human phase 1/2a trial of CRLX101, a cyclodextrin-containing polymer-camptothecin nanopharmaceutical in patients with advanced solid tumor malignancies

enthalten in: Investigational new drugs | 2013

von Weiss, G. | Chao, J. | Neidhart, J. | +22

1
[1]